MedTrace Logo

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance

NCT02254317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-01-28

No results posted yet for this study

Summary

The objective is to identify the lowest effective dose of Grape Seed Extract (GSE) on glucose control in people with impaired glucose tolerance (IGT).

Conditions

  • Impaired Glucose Tolerance

Interventions

DIETARY_SUPPLEMENT

0 mg placebo

Not containing GSE (Placebo)

DIETARY_SUPPLEMENT

300 mg GSE

300 mg GSE

DIETARY_SUPPLEMENT

600 mg GSE

Containing 600 mg of GSE

DIETARY_SUPPLEMENT

900 mg GSE

Containing 900 mg of GSE

Sponsors & Collaborators

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Britt Burton-Freeman, Ph.D · Illinois Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-15
Primary Completion
2015-06-27
Completion
2015-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02254317 on ClinicalTrials.gov